We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
FAE.MC

Price
3.71
Stock movement up
+0.04 (1.23%)
Company name
Faes Farma SA
Exchange
(MC
,
Currency
EUR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
1.15B
Ent value
1.24B
Price/Sales
1.93
Price/Book
1.68
Div yield
-
Div growth
-
Growth years
-
FCF payout
27.30%
Trailing P/E
9.74
Forward P/E
12.22
PEG
-
EPS growth
8.81%
1 year return
16.69%
3 year return
-1.23%
5 year return
1.12%
10 year return
4.55%
Last updated: 2025-04-12

DIVIDENDS

FAE.MC does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E9.74
Price to OCF10.90
Price to FCF25.93
Price to EBITDA9.63
EV to EBITDA10.39

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.93
Price to Book1.68
EV to Sales2.08

FINANCIALS

Per share

Loading...
Per share data
Current share count311.25M
EPS (TTM)0.38
FCF per share (TTM)0.14

Income statement

Loading...
Income statement data
Revenue (TTM)597.59M
Gross profit (TTM)347.69M
Operating income (TTM)161.09M
Net income (TTM)118.42M
EPS (TTM)0.38
EPS (1y forward)0.30

Margins

Loading...
Margins data
Gross margin (TTM)58.18%
Operating margin (TTM)26.96%
Profit margin (TTM)19.82%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash60.73M
Net receivables128.70M
Total current assets346.89M
Goodwill56.41M
Intangible assets128.19M
Property, plant and equipment377.77M
Total assets837.53M
Accounts payable18.76M
Short/Current long term debt43.36M
Total current liabilities126.61M
Total liabilities151.52M
Shareholder's equity686.01M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)105.82M
Capital expenditures (TTM)61.35M
Free cash flow (TTM)44.47M
Dividends paid (TTM)12.14M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity17.26%
Return on Assets14.14%
Return on Invested Capital16.32%
Cash Return on Invested Capital6.13%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.69
Daily high3.73
Daily low3.61
Daily Volume227K
All-time high11.47
1y analyst estimate3.75
Beta0.50
EPS (TTM)0.38
Dividend per share-
Ex-div date9 Jan 2025
Next earnings date-

Downside potential

Loading...
Downside potential data
FAE.MCS&P500
Current price drop from All-time high-67.70%-12.89%
Highest price drop-90.83%-56.47%
Date of highest drop31 May 20129 Mar 2009
Avg drop from high-50.28%-11.07%
Avg time to new high56 days12 days
Max time to new high4602 days1805 days
COMPANY DETAILS
FAE.MC (Faes Farma SA) company logo
Marketcap
1.15B
Marketcap category
Small-cap
Description
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
Employees
1748
Investor relations
-
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The European market recently saw a modest recovery, with the pan-European STOXX Europe 600 Index rising by 0.56%, driven by hopes of increased government spending despite concerns over impending U.S. ...
March 24, 2025
Amidst the backdrop of global trade uncertainties and economic adjustments, European markets have shown resilience, with mixed performances across major indices like Germany's DAX and France's CAC 40....
March 10, 2025
As global markets navigate a landscape marked by record highs in major U.S. indices and political shifts under the Trump administration, small-cap stocks have found themselves overshadowed by their la...
January 27, 2025
In December 2024, global markets are navigating a complex landscape marked by cautious Federal Reserve commentary and political uncertainties, with small-cap indices like the S&P 600 experiencing nota...
December 27, 2024
As global markets continue to navigate a landscape marked by record highs in U.S. indices and robust economic indicators, smaller-cap stocks have been gaining traction, outpacing their larger counterp...
November 28, 2024